BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24013733)

  • 1. First vaccines targeting 'cruise ship virus' sail into clinical trials.
    Willyard C
    Nat Med; 2013 Sep; 19(9):1076-7. PubMed ID: 24013733
    [No Abstract]   [Full Text] [Related]  

  • 2. New insights into the global burden of noroviruses and opportunities for prevention.
    Hall AJ; Glass RI; Parashar UD
    Expert Rev Vaccines; 2016 Aug; 15(8):949-51. PubMed ID: 27142965
    [No Abstract]   [Full Text] [Related]  

  • 3. A norovirus vaccine on the horizon?
    Vinjé J
    J Infect Dis; 2010 Dec; 202(11):1623-5. PubMed ID: 20979457
    [No Abstract]   [Full Text] [Related]  

  • 4. Coordinated European actions to prevent and control norovirus outbreaks on cruise ships.
    Depoortere E; Takkinen J;
    Euro Surveill; 2006 Oct; 11(10):E061018.2. PubMed ID: 17213537
    [No Abstract]   [Full Text] [Related]  

  • 5. Norovirus transmission on cruise ship.
    Isakbaeva ET; Widdowson MA; Beard RS; Bulens SN; Mullins J; Monroe SS; Bresee J; Sassano P; Cramer EH; Glass RI
    Emerg Infect Dis; 2005 Jan; 11(1):154-8. PubMed ID: 15705344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cruising with confidence.
    Bren L
    FDA Consum; 2003; 37(3):34-5. PubMed ID: 12793391
    [No Abstract]   [Full Text] [Related]  

  • 7. Travel by sea: health considerations.
    Wkly Epidemiol Rec; 2007 Aug; 82(34):305-8. PubMed ID: 17715549
    [No Abstract]   [Full Text] [Related]  

  • 8. Norovirus vaccine development: next steps.
    Atmar RL; Estes MK
    Expert Rev Vaccines; 2012 Sep; 11(9):1023-5. PubMed ID: 23151158
    [No Abstract]   [Full Text] [Related]  

  • 9. Cruise ship environmental hygiene and the risk of norovirus infection outbreaks: an objective assessment of 56 vessels over 3 years.
    Carling PC; Bruno-Murtha LA; Griffiths JK
    Clin Infect Dis; 2009 Nov; 49(9):1312-7. PubMed ID: 19814610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norovirus challenges aboard cruise ships.
    Dahl E
    Int Marit Health; 2006; 57(1-4):230-4. PubMed ID: 17312710
    [No Abstract]   [Full Text] [Related]  

  • 11. Norovirus: Facts and Reflections from Past, Present, and Future.
    Lucero Y; Matson DO; Ashkenazi S; George S; O'Ryan M
    Viruses; 2021 Nov; 13(12):. PubMed ID: 34960668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of Protection against Norovirus Infection and Disease-Where Are We Now, Where Do We Go?
    Ramani S; Estes MK; Atmar RL
    PLoS Pathog; 2016 Apr; 12(4):e1005334. PubMed ID: 27115358
    [No Abstract]   [Full Text] [Related]  

  • 13. Disease transmission and passenger behaviors during a high morbidity Norovirus outbreak on a cruise ship, January 2009.
    Wikswo ME; Cortes J; Hall AJ; Vaughan G; Howard C; Gregoricus N; Cramer EH
    Clin Infect Dis; 2011 May; 52(9):1116-22. PubMed ID: 21429864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious diseases. Gastrointestinal virus strikes European cruise ships.
    Enserink M
    Science; 2006 Aug; 313(5788):747. PubMed ID: 16902100
    [No Abstract]   [Full Text] [Related]  

  • 15. Progress toward norovirus vaccines: considerations for further development and implementation in potential target populations.
    Aliabadi N; Lopman BA; Parashar UD; Hall AJ
    Expert Rev Vaccines; 2015; 14(9):1241-53. PubMed ID: 26224658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular diversity of noroviruses associated with outbreaks on cruise ships: comparison with strains circulating within the UK.
    Gallimore CI; Richards AF; Gray JJ
    Commun Dis Public Health; 2003 Dec; 6(4):285-93. PubMed ID: 15067852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical profile of children with norovirus disease in rotavirus vaccine era.
    Wikswo ME; Desai R; Edwards KM; Staat MA; Szilagyi PG; Weinberg GA; Curns AT; Lopman B; Vinjé J; Parashar UD; Payne DC; Hall AJ
    Emerg Infect Dis; 2013 Oct; 19(10):1691-3. PubMed ID: 24047618
    [No Abstract]   [Full Text] [Related]  

  • 18. The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and Control.
    Lopman BA; Steele D; Kirkwood CD; Parashar UD
    PLoS Med; 2016 Apr; 13(4):e1001999. PubMed ID: 27115709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential economic value of a human norovirus vaccine for the United States.
    Bartsch SM; Lopman BA; Hall AJ; Parashar UD; Lee BY
    Vaccine; 2012 Nov; 30(49):7097-104. PubMed ID: 23026689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norovirus Vaccine: Priorities for Future Research and Development.
    Esposito S; Principi N
    Front Immunol; 2020; 11():1383. PubMed ID: 32733458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.